You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 545 A phase II randomized window of opportunity trial evaluating cytotoxic and immunomodulatory effects of intratumoral INT230-6 (cisplatin, vinblastine) in early stage breast cancer: the INVINCIBLE trial

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials Completed
545 A phase II randomized window of opportunity trial evaluating cytotoxic and immunomodulatory effects of intratumoral INT230-6 (cisplatin, vinblastine) in early stage breast cancer: the INVINCIBLE trial
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to September 2024

AbstractFullPdf
Nov 2022198012
Dec 20226005
Jan 20232004
Feb 20232802
Mar 20231801
Apr 20232201
May 20233001
Jun 20233001
Jul 20233004
Aug 2023202
Sep 2023402
Oct 20232602
Nov 20231601
Dec 20234607
Jan 20243201
Feb 20242602
Mar 20241809
Apr 20242004
May 20243002
Jun 20242605
Jul 20241805
Aug 20242201
Sep 20242203
Total744077